Author

Farzan Siddiqui

Henry Ford HealthORCID 0000-0003-1547-835XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

Benjamin MovsasiD· 2 shared Oudai Hassan· 2 shared Shivani ThoidingjamiD· 2 shared Shyam NyatiiD· 2 shared Stephen L. BrowniD· 2 shared Anthony J. DavisiD· 1 shared Corey Wayne SpeersiD· 1 shared Eleanor WalkeriD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Benjamin MovsasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedSep 27, 2024

BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy

Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan…·Shyam Nyati

This study shows BUB1 inhibition enhances the effectiveness of radiotherapy and chemoradiation in lung cancer cell lines.

14 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedJun 11, 2024

BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer

Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen…·Shyam Nyati

This study identifies BUB1 as a regulator of non-homologous end joining (NHEJ) in triple-negative breast cancer (TNBC), showing that its inhibition sensitizes TNBC cells to radiotherapy.

22 citations

humanbulk RNA-seq

𝕏 PostBluesky